Aemetis Inc. (AMTX)
Aemetis to Benefit From EPA's Approval of 15 Percent Ethanol Blend
Consumers are expected to save up to $0.20 per gallon at the pump Listened: CUPERTINO, Calif., April 29, 2025 – PRISM MediaWire – Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced today that the U.S.
Aemetis India Begins Biodiesel Shipments to Oil Marketing Companies under $31 Million Allocation For the Next Three Months
Listen: CUPERTINO, Calif., April 24, 2025 – PRISM MediaWire – Aemetis, Inc.
Aemetis India Plant Visited by U.S. Consul General
Listen: CUPERTINO, Calif., April 23, 2025 – PRISM MediaWire – Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company's subsidiary in India, Universal Biofuels, has been working with the U.S. government to support the success of American interests in India.
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months
Listen: CUPERTINO, Calif., April 21, 2025 – PRISM MediaWire – Aemetis, Inc.
Aemetis Biogas Monthly RNG Production Increased by 55% in March
Sales of LCFS credits and D3 RINs completed at the end of Q1 CUPERTINO, Calif., April 08, 2025 – PRISM MediaWire – Aemetis, Inc.
Aemetis, Inc. (AMTX) Q4 2024 Earnings Call Transcript
Aemetis, Inc. (NASDAQ:AMTX ) Q4 2024 Earnings Conference Call March 13, 2025 2:00 PM ET Company Participants Todd Waltz - EVP, CFO Eric McAfee - Founder, Chairman and CEO Andy Foster - President of Aemetis Advanced Fuels Conference Call Participants Jordan Levy - Truist Securities Sameer Joshi - HC Wainwright Derrick Whitfield - Texas Capital Matthew Blair - Tudor, Pickering, Holt & Co Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Welcome to the Aemetis Fourth Quarter and Year End 2024 Earnings Review Conference Call. At this time, all participants are in a listen-only mode.
Aemetis: I Have Serious Concerns
Aemetis faces severe financial distress, with their SEC Filing raising "substantial doubts" about their ability to "continue as a going concern". Most notably, they face impending debt maturities as well as a lack of profitability with almost non-existent gross margins. Their equity issuances are highly dilutive due to a weak share price, and thus they are not a viable strategy to relieve their financial distress.
Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript
Aemetis, Inc. (NASDAQ:AMTX ) Q3 2024 Earnings Call November 12, 2024 2:00 PM ET Company Participants Todd Waltz - Executive Vice President and Chief Financial Officer Eric McAfee - Founder, Chairman and Chief Executive Officer Andy Foster - President, North America Conference Call Participants Manav Gupta - UBS Henry Stephen - Truist Amit Dayal - H.C. Wainwright Matthew Blair - TPH Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Good day, ladies and gentlemen, and welcome to the Aemetis Third Quarter 2024 Earnings Review Conference Call.
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
Aemetis (AMTX) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.59 per share a year ago.
Aemetis, Inc. (AMTX) Q2 2024 Earnings Call Transcript
Aemetis, Inc. (NASDAQ:AMTX ) Q2 2024 Earnings Conference Call August 1, 2024 2:00 PM ET Company Participants Todd Waltz - Executive Vice President & Chief Financial Officer Eric McAfee - Founder, Chairman & Chief Executive Officer Andy Foster - President, North America Conference Call Participants Manav Gupta - UBS Jordan Levy - Truist Matthew Blair - TPH Amit Dayal - H.C. Wainwright Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Greetings and welcome to the Aemetis Second Quarter 2024 Earnings Review Conference Call.
Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates
Aemetis (AMTX) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.68 per share a year ago.
7 Cheap Stocks Under $10 With 10X Potential: July 2024
Many cheap stocks under $10 are cheap for a good reason. Cash-burning biotechs, sketchy shell companies and overhyped fads with more sizzle than substance.
